Synthesis by Jeffrey Bland

Latest Issue  

December 2014 - In this issue, Dr. Bland interviews C. Ronald Kahn, MD. Dr. Kahn is Chief Academic Officer of the world-renowned Joslin Diabetes Center in Massachusetts, which is academically affiliated with Harvard University. Dr. Kahn is considered a pioneer in the study of insulin signaling. His discoveries have been key in moving the field of diabetes research forward, and his work continues to uncover new findings related to diabetes, obesity, and insulin resistance.

Learn more about Dr. Kahn here.

Take note   

Dr. Bland has stepped down from the Metagenics Board of Directors as of 9/9/2014. Press Release

Upcoming Speaking Events:

Nov 13-16   ACAM Fall Meeting 

Jan 15-18    Scripps Natural Supplements

Feb 19-21   Integrative Healthcare Symposium

What's Dr. Bland Reading?   

"Translational Genomics. Clues from the Resilient" Read the abstract.

"The Hunt for Unexpected Genetic Heroes" Watch the TEDtalk.

"The New Normal" Nutrition Business Journal. Find the article.

"Medicine Gets Up Close and Personal" Read the abstract.

"PALB2 Mutations and Breast-Cancer Risk." Read the full text

Inheritance: How Our Genes Change Our Lives--and Our Lives Change Our Genes by Sharon Moalem, MD, PhD. Find it here.